Ledyard National Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ledyard National Bank’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-114	Closed	-$26K	–	305
2018 Q4	$26K	Hold	114	–	–	﹤0.01%	488
2018 Q3	$36K	Hold	114	–	–	﹤0.01%	454
2018 Q2	$33K	Hold	114	–	–	﹤0.01%	470
2018 Q1	$29K	Hold	114	–	–	﹤0.01%	497
2017 Q4	$27K	Hold	114	–	–	﹤0.01%	529
2017 Q3	$25K	Hold	114	–	–	﹤0.01%	525
2017 Q2	$26K	Hold	114	–	–	﹤0.01%	475
2017 Q1	$23K	Hold	114	–	–	﹤0.01%	502
2016 Q4	$21K	Hold	114	–	–	﹤0.01%	396
2016 Q3	$19K	Hold	114	–	–	﹤0.01%	411
2016 Q2	$16K	Hold	114	–	–	﹤0.01%	416
2016 Q1	$16K	Hold	114	–	–	﹤0.01%	470
2015 Q4	$16K	Hold	114	–	–	﹤0.01%	458
2015 Q3	$15K	Hold	114	–	–	﹤0.01%	444
2015 Q2	$17K	Hold	114	–	–	﹤0.01%	437
2015 Q1	$15K	Hold	114	–	–	﹤0.01%	444
2014 Q4	$14K	Hold	114	–	–	﹤0.01%	474
2014 Q3	$13K	Hold	114	–	–	﹤0.01%	433
2014 Q2	$14K	Hold	114	–	–	﹤0.01%	433
2014 Q1	$15K	Hold	114	–	–	﹤0.01%	409
2013 Q4	$14K	Buy	+114	New	+$13.9K	﹤0.01%	427

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Ledyard National Bank's BIO Position: Q1 2019 in Review

Ledyard National Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2019, closing a stake of 114 shares — an estimated $26K sold.

Ledyard National Bank first reported a position in BIO in Q4 2013 and held it in 21 quarters. The position peaked at $36K in Q3 2018. 347 funds tracked by Wall St. Rank hold BIO as of Q1 2019.

Ledyard National Bank reported no remaining Bio-Rad Laboratories Class A position as of Q1 2019 after selling out during the quarter.
Ledyard National Bank sold 114 Bio-Rad Laboratories Class A shares in Q1 2019, an estimated $26K.
Ledyard National Bank first reported a position in Bio-Rad Laboratories Class A in Q4 2013 and held it in 21 quarters.
Ledyard National Bank's Bio-Rad Laboratories Class A position peaked at $36K in Q3 2018.
347 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.